How U.S.-Built Manufacturing Equipment Is Powering a More Resilient Global Supply Chain
As we explored in our recent power series, access to reliable energy has become a strategic priority for companies across manufacturing, logistics, and data-intensive industries. Energy capacity is increasingly tied to competitiveness, influencing where facilities are located and how quickly Operators can scale.
But power is only one side of the industrial equation.
The next challenge and opportunity is production capacity.
Across the world, organizations are reassessing how essential goods are manufactured and how supply chains can be strengthened for long-term stability. For sectors like healthcare, medical supplies, and critical-use consumables, the ability to produce locally has become a strategic priority.
This shift is influencing capital decisions, equipment procurement, and infrastructure planning across multiple regions (McKinsey & Company, 2023).
Why Production Capacity Is Becoming a Global Priority
In many markets, companies want to produce more of their essential goods closer to home. The goal is not to abandon global supply chains, but to reinforce them, creating redundancies, shortening lead times, and reducing reliance on a small number of overseas manufacturers.
Three dynamics are shaping this movement:
1. Demand for localized production
Healthcare systems, large distributors, and industrial operators recognize value in diversifying where critical products are made. Local production can help mitigate shipping risks, improve responsiveness, and support regional economic stability.
2. Operators need access, not ownership
Even when organizations want to bring production online, many prefer not to purchase highly specialized equipment outright. They want:
- predictable costs
- flexible deployment
- minimal long-term capital commitments
- the ability to scale production efficiently
This preference mirrors trends across multiple industries where leasing specialized machinery has become a commonly used model.
3. The bottleneck is equipment, not demand
In several categories, including PPE production, global demand is not the challenge. The limiting factor is access to the machines capable of producing goods efficiently, reliably, and at scale.
This is where U.S.-built manufacturing technology is stepping into the spotlight.
U.S.-Engineered Production Systems: A Different Approach
US Medical Glove Company (USMGC) has developed a new generation of glove-production machinery, engineered and manufactured in the United States. These systems are part of USMGC’s effort to expand U.S.-based manufacturing of critical-use PPE and reduce reliance on foreign-made equipment.
Designed to help operators stand up production lines more efficiently, interest in these production systems extends beyond the domestic market, as organizations overseas evaluate ways to strengthen their own supply chains and expand access to PPE manufacturing capabilities.
The Role of CAI’s Equipment Leasing Initiative
To help meet global demand for these systems, CAI Investments is preparing to launch the Equipment Leasing Fund, which will purchase USMGC machines and lease them to qualified operators around the world.
This approach is designed to:
- provide operators with access to equipment without requiring them to purchase machines outright
- streamline deployment of U.S.-engineered systems
- support the scaling of localized PPE production
- strengthen supply-chain resilience through distributed manufacturing
By aligning manufacturing, financing, and production functions, this structure helps facilitate the deployment of U.S.-engineered equipment to regions that need it.
Next, we’ll take a closer look at how equipment leasing plays a role in expanding production capacity around the world and why many operators choose flexibility over ownership.
For more information:
Contact our team to learn how we identify and develop properties that support U.S. manufacturing growth and energy resilience.
Comments